Biogen Free Cash Flow vs Accounts Payable Analysis

BIIB Stock

USD 196.80 1.38 0.70%

Biogen financial indicator trend analysis is way more than just evaluating Biogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biogen Inc is a good investment. Please check the relationship between Biogen Free Cash Flow and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Free Cash Flow vs Accounts Payable

Free Cash Flow vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biogen Inc Free Cash Flow account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Biogen's Free Cash Flow and Accounts Payable is 0.52. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Biogen Inc, assuming nothing else is changed. The correlation between historical values of Biogen's Free Cash Flow and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Biogen Inc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Free Cash Flow i.e., Biogen's Free Cash Flow and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.52

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Accounts Payable

An accounting item on the balance sheet that represents Biogen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Biogen Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 17.67, whereas Tax Provision is forecasted to decline to about 128.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	8.9B	7.9B	7.3B	3.9B
Total Revenue	11.0B	10.2B	9.8B	10.3B

Gross Profit Total Revenue

Biogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Common Stock	Short Term Debt
Total Assets		0.92	0.67	0.95	0.94	0.96	0.85	0.99	0.63	0.99	-0.57	0.61	0.97	-0.74	0.94	0.56	-0.82	0.96	0.86	0.93	0.59	0.89	-0.8	0.3	-0.8	0.39
Short Long Term Debt Total	0.92		0.63	0.86	0.76	0.89	0.96	0.9	0.58	0.9	-0.72	0.59	0.85	-0.62	0.98	0.54	-0.92	0.97	0.8	0.87	0.45	0.83	-0.63	0.33	-0.63	0.29
Other Current Liab	0.67	0.63		0.78	0.53	0.64	0.46	0.63	0.79	0.58	-0.43	0.88	0.59	-0.67	0.69	0.45	-0.64	0.73	0.24	0.79	-0.1	0.73	-0.56	0.74	-0.56	0.44
Total Current Liabilities	0.95	0.86	0.78		0.85	0.92	0.75	0.91	0.72	0.92	-0.53	0.67	0.88	-0.74	0.89	0.45	-0.79	0.94	0.75	0.9	0.43	0.94	-0.74	0.34	-0.74	0.52
Total Stockholder Equity	0.94	0.76	0.53	0.85		0.89	0.68	0.94	0.56	0.93	-0.37	0.52	0.95	-0.73	0.78	0.54	-0.63	0.82	0.86	0.87	0.7	0.79	-0.85	0.18	-0.85	0.29
Property Plant And Equipment Net	0.96	0.89	0.64	0.92	0.89		0.82	0.92	0.59	0.96	-0.5	0.54	0.95	-0.78	0.92	0.56	-0.75	0.94	0.88	0.87	0.5	0.95	-0.78	0.21	-0.78	0.44
Net Debt	0.85	0.96	0.46	0.75	0.68	0.82		0.83	0.33	0.86	-0.7	0.38	0.78	-0.5	0.94	0.48	-0.86	0.91	0.81	0.73	0.54	0.71	-0.56	0.22	-0.56	0.22
Retained Earnings	0.99	0.9	0.63	0.91	0.94	0.92	0.83		0.63	0.97	-0.62	0.6	0.97	-0.66	0.92	0.51	-0.85	0.94	0.85	0.93	0.61	0.83	-0.73	0.28	-0.73	0.33
Cash	0.63	0.58	0.79	0.72	0.56	0.59	0.33	0.63		0.51	-0.41	0.9	0.59	-0.64	0.59	0.42	-0.6	0.64	0.3	0.83	-0.07	0.72	-0.47	0.52	-0.47	0.34
Non Current Assets Total	0.99	0.9	0.58	0.92	0.93	0.96	0.86	0.97	0.51		-0.55	0.49	0.96	-0.69	0.93	0.52	-0.78	0.95	0.91	0.86	0.67	0.86	-0.78	0.18	-0.78	0.4
Non Currrent Assets Other	-0.57	-0.72	-0.43	-0.53	-0.37	-0.5	-0.7	-0.62	-0.41	-0.55		-0.38	-0.52	0.14	-0.72	-0.2	0.87	-0.68	-0.46	-0.55	-0.26	-0.47	0.06	-0.2	0.06	-0.18
Cash And Short Term Investments	0.61	0.59	0.88	0.67	0.52	0.54	0.38	0.6	0.9	0.49	-0.38		0.53	-0.6	0.61	0.53	-0.6	0.64	0.18	0.84	-0.14	0.62	-0.55	0.83	-0.55	0.37
Net Receivables	0.97	0.85	0.59	0.88	0.95	0.95	0.78	0.97	0.59	0.96	-0.52	0.53		-0.71	0.88	0.52	-0.77	0.9	0.88	0.89	0.6	0.85	-0.75	0.18	-0.75	0.32
Common Stock Shares Outstanding	-0.74	-0.62	-0.67	-0.74	-0.73	-0.78	-0.5	-0.66	-0.64	-0.69	0.14	-0.6	-0.71		-0.64	-0.57	0.42	-0.68	-0.56	-0.75	-0.26	-0.8	0.85	-0.36	0.85	-0.28
Non Current Liabilities Total	0.94	0.98	0.69	0.89	0.78	0.92	0.94	0.92	0.59	0.93	-0.72	0.61	0.88	-0.64		0.55	-0.92	0.99	0.79	0.88	0.43	0.85	-0.65	0.37	-0.65	0.39
Other Current Assets	0.56	0.54	0.45	0.45	0.54	0.56	0.48	0.51	0.42	0.52	-0.2	0.53	0.52	-0.57	0.55		-0.33	0.53	0.43	0.6	0.19	0.51	-0.65	0.43	-0.65	0.05
Other Stockholder Equity	-0.82	-0.92	-0.64	-0.79	-0.63	-0.75	-0.86	-0.85	-0.6	-0.78	0.87	-0.6	-0.77	0.42	-0.92	-0.33		-0.9	-0.64	-0.81	-0.32	-0.71	0.37	-0.37	0.37	-0.33
Total Liab	0.96	0.97	0.73	0.94	0.82	0.94	0.91	0.94	0.64	0.95	-0.68	0.64	0.9	-0.68	0.99	0.53	-0.9		0.79	0.91	0.44	0.89	-0.69	0.37	-0.69	0.44
Property Plant And Equipment Gross	0.86	0.8	0.24	0.75	0.86	0.88	0.81	0.85	0.3	0.91	-0.46	0.18	0.88	-0.56	0.79	0.43	-0.64	0.79		0.67	0.78	0.76	-0.65	-0.17	-0.65	0.25
Total Current Assets	0.93	0.87	0.79	0.9	0.87	0.87	0.73	0.93	0.83	0.86	-0.55	0.84	0.89	-0.75	0.88	0.6	-0.81	0.91	0.67		0.35	0.85	-0.76	0.53	-0.76	0.33
Intangible Assets	0.59	0.45	-0.1	0.43	0.7	0.5	0.54	0.61	-0.07	0.67	-0.26	-0.14	0.6	-0.26	0.43	0.19	-0.32	0.44	0.78	0.35		0.32	-0.53	-0.35	-0.53	-0.08
Accounts Payable	0.89	0.83	0.73	0.94	0.79	0.95	0.71	0.83	0.72	0.86	-0.47	0.62	0.85	-0.8	0.85	0.51	-0.71	0.89	0.76	0.85	0.32		-0.71	0.25	-0.71	0.5
Common Stock Total Equity	-0.8	-0.63	-0.56	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.75	0.85	-0.65	-0.65	0.37	-0.69	-0.65	-0.76	-0.53	-0.71		-0.36	1.0	-0.22
Short Term Investments	0.3	0.33	0.74	0.34	0.18	0.21	0.22	0.28	0.52	0.18	-0.2	0.83	0.18	-0.36	0.37	0.43	-0.37	0.37	-0.17	0.53	-0.35	0.25	-0.36		-0.36	0.29
Common Stock	-0.8	-0.63	-0.56	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.75	0.85	-0.65	-0.65	0.37	-0.69	-0.65	-0.76	-0.53	-0.71	1.0	-0.36		-0.22
Short Term Debt	0.39	0.29	0.44	0.52	0.29	0.44	0.22	0.33	0.34	0.4	-0.18	0.37	0.32	-0.28	0.39	0.05	-0.33	0.44	0.25	0.33	-0.08	0.5	-0.22	0.29	-0.22

Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Short Long Term Debt Total	6.4B	7.8B	7.6B	6.6B	7.3B	7.7B
Other Current Liab	3.4B	3.3B	3.3B	2.8B	838.4M	969.8M
Total Current Liabilities	4.9B	3.7B	4.3B	3.3B	3.4B	3.6B
Total Stockholder Equity	13.3B	10.7B	11.0B	13.4B	14.8B	15.5B
Property Plant And Equipment Net	3.7B	3.8B	3.8B	3.7B	3.7B	3.9B
Net Debt	3.5B	6.5B	5.3B	3.2B	6.3B	6.6B
Retained Earnings	16.5B	14.0B	13.9B	16.5B	17.6B	18.5B
Cash	2.9B	1.3B	2.3B	3.4B	1.0B	723.1M
Non Current Assets Total	18.9B	17.7B	16.0B	14.8B	20.0B	21.0B
Non Currrent Assets Other	(3.2B)	(1.4B)	1.9B	1.5B	284.3M	270.1M
Cash And Short Term Investments	4.5B	2.6B	3.8B	4.9B	1.0B	1.5B
Net Receivables	1.9B	1.9B	1.5B	2.1B	2.1B	2.2B
Common Stock Shares Outstanding	187.4M	161.3M	149.6M	146M	145.6M	283.0M
Liabilities And Stockholders Equity	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Non Current Liabilities Total	9.0B	10.2B	8.6B	7.9B	8.6B	9.0B
Other Current Assets	1.2B	1.3B	1.2B	1.4B	1.2B	1.2B
Other Stockholder Equity	(3.0B)	(3.0B)	(2.8B)	(2.9B)	(2.7B)	(2.5B)
Total Liab	13.9B	13.9B	12.9B	11.2B	12.0B	12.6B
Property Plant And Equipment Gross	3.7B	3.8B	3.8B	3.7B	6.1B	6.4B
Total Current Assets	8.4B	6.9B	7.9B	9.8B	6.9B	7.2B
Accumulated Other Comprehensive Income	(135.2M)	(299M)	(106.7M)	(164.9M)	(153.7M)	(146.0M)
Intangible Assets	3.5B	3.1B	2.2B	1.9B	8.4B	8.8B
Accounts Payable	530.8M	454.9M	589.2M	491.5M	403.3M	423.5M
Short Term Investments	2.3B	1.6B	1.3B	1.5B	1.5B	0.0
Inventory	804.2M	1.1B	1.4B	1.3B	2.5B	2.7B
Other Liab	4.2B	2.4B	2.0B	1.3B	1.5B	969.6M
Other Assets	3.2B	4.2B	3.4B	1.7B	1.9B	2.0B
Long Term Debt	4.5B	7.4B	6.3B	6.3B	6.8B	7.1B
Property Plant Equipment	3.2B	3.4B	3.4B	3.3B	3.8B	2.1B
Good Will	5.8B	5.8B	5.8B	5.7B	6.2B	3.2B
Net Tangible Assets	4.1B	1.9B	2.9B	5.8B	6.7B	4.1B
Noncontrolling Interest In Consolidated Entity	(4.1M)	(14.2M)	63.5M	(9.5M)	(8.6M)	(8.1M)
Retained Earnings Total Equity	16.5B	14.0B	13.9B	16.5B	18.9B	11.5B

Biogen Investors Sentiment

The influence of Biogen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biogen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biogen.

Biogen Implied Volatility

173.85

Biogen's implied volatility exposes the market's sentiment of Biogen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biogen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biogen stock will not fluctuate a lot when Biogen's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biogen's short interest history, or implied volatility extrapolated from Biogen options trading.

Pair Trading with Biogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biogen Stock

0.8

VRTX

Vertex Pharmaceuticals Financial Report 6th of May 2024

Pair Corr

Moving against Biogen Stock

0.91	RZLT	Rezolute Trending	Pair Corr
0.79	INDP	Indaptus Therapeutics Financial Report 9th of May 2024	Pair Corr
0.78	CELC	Celcuity LLC Financial Report 20th of May 2024	Pair Corr
0.77	NVO	Novo Nordisk AS Financial Report 2nd of May 2024	Pair Corr
0.66	ERAS	Erasca Inc Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.

The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Bonds Directory Find actively traded corporate debentures issued by US companies

Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.55)

Earnings Share

7.97

Revenue Per Share

67.972

Quarterly Revenue Growth

(0.06)

Return On Assets

0.0458

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Free Cash Flow vs Accounts Payable Analysis

Free Cash Flow vs Accounts Payable

Free Cash Flow vs Accounts Payable Correlation Analysis

Correlation Coefficient

Free Cash Flow

Accounts Payable

Biogen fundamental ratios Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen fundamental ratios Accounts

Biogen Investors Sentiment

Biogen Implied Volatility

Pair Trading with Biogen

Moving together with Biogen Stock

Moving against Biogen Stock

Complementary Tools for Biogen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Retained Earnings	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Net Receivables	+ 0.97	Total Assets

Other Stockholder Equity	- 0.92	Non Current Liabilities Total
Other Stockholder Equity	- 0.92	Short Long Term Debt Total
Total Liab	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Net Debt
Other Stockholder Equity	- 0.85	Retained Earnings
Common Stock	- 0.85	Total Stockholder Equity